NPY1-R Inhibitors

BIBP 3226 is a selective and potent non-peptide antagonist of NPY1-R, used extensively in research to study the role of NPY1-R in physiological processes.

BMS 193885 acts as a selective antagonist for the neuropeptide Y1 receptor, showcasing unique binding characteristics that influence receptor conformation. Its molecular structure facilitates specific hydrogen bonding and hydrophobic interactions, enhancing its affinity. The compound exhibits distinct allosteric modulation, impacting intracellular signaling pathways. Additionally, its reaction kinetics reveal a slow onset of action, indicating a sustained influence on receptor activity, which may affect downstream physiological responses.

BIBO 3304 trifluoroacetate functions as a selective modulator of the neuropeptide Y1 receptor, characterized by its ability to stabilize receptor conformations through unique electrostatic interactions. The trifluoroacetate moiety enhances solubility and promotes specific ligand-receptor dynamics, leading to altered signaling cascades. Its kinetic profile suggests a rapid association with the receptor, followed by a prolonged dissociation phase, allowing for nuanced regulation of receptor-mediated effects.

GR 231118 acts as a selective antagonist at the neuropeptide Y1 receptor, exhibiting unique binding characteristics that disrupt typical receptor-ligand interactions. Its structural features facilitate specific hydrogen bonding and hydrophobic contacts, influencing receptor conformation and downstream signaling pathways. The compound demonstrates a distinctive kinetic behavior, with a fast initial binding phase followed by a gradual release, enabling fine-tuned modulation of receptor activity.

BIIE0246 is a highly selective and potent non-peptide antagonist of NPY1-R, useful in dissecting the physiological roles of NPY1-R.